Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 8.8B | 9.5B | 9.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.9B | 7.8B | 8.3B | 8.4B |
Operating income | 778M | 756M | 1.0B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 647M | 626M | 881M | 958M |
Tax provision | 165M | 169M | 215M | 230M |
Net income | 482M | 457M | 666M | 728M |
Basic EPS | 0.9 | 0.9 | 1.3 | 1.4 |
Diluted EPS | 0.9 | 0.9 | 1.3 | 1.4 |
Basic average shares | 506.9M | 506.7M | 505.4M | 507.0M |
Diluted average shares | 506.9M | 506.7M | 505.4M | 507.0M |
EBITDA | 1.0B | 1.0B | 1.3B | 1.3B |
Net income from continuing op. | 778M | 756M | 1.0B | 1.1B |
Minority interests | -4M | -6M | -8M | -8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |